Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
2000 Turkeys
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
2000 Turkeys
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
PolyPid (PYPD) Q3 2026 Earnings Call Transcript
↗
November 11, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
PYPD
Exposures
Financial
Product Safety
Exelixis Nears FDA Decision, Key Kidney Cancer Data for Zanzalintinib
↗
November 11, 2026
Via
MarketBeat
Tickers
EXEL
Exposures
Product Safety
A Billionaire Investor Links Cancer Treatment and Wireless Technology as AI Pharmaceutical Testing Gains Ground
November 11, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Tickers
IBRX
LLY
PDSB
PRSO
VIVS
Exposures
Artificial Intelligence
Product Safety
Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
November 11, 2026
Via
PRLog
Exposures
Product Safety
What MiNK Therapeutics (INKT) Said on Its Q3 Earnings Call
↗
November 11, 2026
Via
MarketBeat
Topics
Earnings
Tickers
INKT
Exposures
Financial
Product Safety
What PolyPid (PYPD) Said on Its Q3 Earnings Call
↗
November 11, 2026
Via
MarketBeat
Topics
Earnings
Tickers
PYPD
Exposures
Financial
Product Safety
Study Discovers Possible Reason for Immunotherapy Not Working in Some Patients
November 11, 2026
Via
Investor Brand Network
Tickers
CLDI
Exposures
Product Safety
Incyte Maps Post-Jakafi Growth, Targeting Up to $4 Billion in Other Sales by 2030
↗
November 11, 2026
Via
MarketBeat
Tickers
INCY
Exposures
Product Safety
Definium Therapeutics Eyes FDA Filing for LSD Treatment After Three Positive Phase 3 Studies
↗
November 11, 2026
Via
MarketBeat
Tickers
ARM
DFTX
Exposures
Product Safety
DownTown Mystic Revisits On E Street 4 The Holidays
November 11, 2026
Via
24-7 Press Release
Topics
Product Recall
Exposures
Legal
Product Safety
Exelixis Bets on Zanza as Next Cancer Franchise as FDA Decision Nears
↗
November 11, 2026
Via
MarketBeat
Topics
Intellectual Property
Tickers
EXEL
Exposures
Intellectual Property
Product Safety
Geron Targets Germany Launch and Deals as RYTELO Sales Grow
↗
November 10, 2026
Via
MarketBeat
Tickers
GERN
Exposures
Product Safety
Inovio (INO) Q3 2026 Earnings Call Transcript
↗
November 10, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
INO
Exposures
Financial
Product Safety
Capricor (CAPR) Q3 2026 Earnings Call Transcript
↗
November 10, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
CAPR
Exposures
Financial
Product Safety
Freenome Q3 Earnings Call Highlights
↗
November 10, 2026
Via
MarketBeat
Topics
Earnings
Tickers
FRNM
Exposures
Financial
Product Safety
Inovio Pharmaceuticals Q3 Earnings Call Highlights
↗
November 10, 2026
Via
MarketBeat
Topics
Earnings
Tickers
INO
PLTR
Exposures
Financial
Product Safety
Kura Oncology Q3 Earnings Call Highlights
↗
November 10, 2026
Via
MarketBeat
Topics
Earnings
Tickers
KURA
Exposures
Financial
Product Safety
What Grocery Outlet (GO) Said on Its Q3 Earnings Call
↗
November 10, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Credit Cards
Earnings
Tickers
GO
Exposures
Artificial Intelligence
Financial
Interest Rates
Capricor Therapeutics Q3 Earnings Call Highlights
↗
November 10, 2026
Via
MarketBeat
Topics
Earnings
Tickers
CAPR
Exposures
Financial
Product Safety
Got $10,000? 3 Hot Stocks to Buy That Could Make You a Fortune
↗
November 10, 2026
Via
The Motley Fool
Tickers
AGLT
AMZN
ASX:SFC
GRAL
GXO
MELI
Exposures
Product Safety
TriSalus (TLSI) Q3 2026 Earnings Call Transcript
↗
November 10, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
TLSI
Exposures
Financial
Product Safety
Scholar Rock (SRRK) Q3 2026 Earnings Call Transcript
↗
November 10, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
SRRK
Exposures
Financial
Product Safety
FDA Rejects NovoCure’s Optune Mya for Lung Cancer Brain Metastases. Here's What It Means for Investors.
↗
November 10, 2026
Via
The Motley Fool
Tickers
NVCR
Exposures
Product Safety
What Legend Biotech (LEGN) Said on Its Q3 Earnings Call
↗
November 10, 2026
Via
MarketBeat
Topics
Earnings
Tickers
LEGN
Exposures
Financial
Product Safety
PEMEC’s Apprentice-Turned-CEO Backs Hull Talent With 18,000 Sq Ft Expansion
November 10, 2026
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Legal
Product Safety
What Hemab Therapeutics (COAG) Said on Its Q3 Earnings Call
↗
November 10, 2026
Via
MarketBeat
Topics
Earnings
Tickers
COAG
Exposures
Financial
Product Safety
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Publishes Phase 1a Glioblastoma Data, Advances LP-184 Combination Therapy Toward Phase 1b/2a Trial
November 10, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Tickers
LTRN
Exposures
Artificial Intelligence
Product Safety
BioMedNewsBreaks – NanoViricides (NYSE American: NNVC) Advances NV-387 Measles Treatment Toward Phase II Clinical Trials
November 10, 2026
Via
Investor Brand Network
Topics
Intellectual Property
Tickers
NNVC
Exposures
COVID-19
Intellectual Property
Product Safety
Vir Biotechnology Hepatitis Delta Treatment Meets Phase III Goals, With 79% Virus-Free at Week 48
↗
November 10, 2026
Via
MarketBeat
Tickers
VIR
Exposures
Product Safety
OS Therapies Initiates U.K. MHRA Conditional Marketing Authorisation Application for Herlystic (OST-HER2) in the Prevention or Delay of Recurrence in Fully Resected, Pulmonary Metastatic Osteosarcoma
November 10, 2026
Via
Newsfile
Tickers
OSTX
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today